semaglutide affect period and metformin improve menstrual cyclicity in overweight/obese women with polycystic ovary syndrome: a randomized trial How Long Does Semaglutide Take

Colleen McCabe, PharmD, BCOP, and Lindsay Mundy, PharmD, BCOP, provided an engaging exploration of the benefits and potential pitfalls seen with the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in an oncology setting

Clinical audiences are equally impressed with the data, hailing a new era for how obesity is perceived and treated, notwithstanding the missed statistical significance for cardiovascular death and the other secondary confirmatory endpoints not being tested for superiority as a consequence

The world's first GLP-1 weight-loss treatment for pets has begun with successful cat dosing

Body composition analysis, including fat and lean mass, was performed using the Echo-MRI system, revealing significant suppression of both fat and lean mass by all three GLP-1 analogs

#GLP-1 #Semaglutide #Tirzepatide #weightloss #diabetes

Purpose of Review The impact of GLP1 receptor agonist (GLP1-RA) medications on eating disorders is not established in large scale clinical trials with adult or pediatric populations